Mobidiag Earns CE Mark for Two COVID-19 PCR Tests

Finnish diagnostic maker Mobidiag’s two COVID-19 polymerase chain reaction (PCR) tests  have received CE mark certification.

The Novodiag and Amplidiag coronavirus tests are used for early detection of the virus in patients with signs and symptoms of respiratory infection.

The Novodiag test provides results within one hour, using nasopharyngeal swabs, while the Amplidiag large-volume test allows 48 samples to be processed in under three hours.